The University of Chicago Header Logo

Connection

Peter H. O'Donnell to Pyrazines

Back to Details
This is a "connection" page, showing publications Peter H. O'Donnell has written about Pyrazines.
Peter H. O'Donnell
Connection Strength
0.180
Pyrazines
  1. A randomized phase 2 trial of pembrolizumab versus pembrolizumab and acalabrutinib in patients with platinum-resistant metastatic urothelial cancer. Cancer. 2020 10 15; 126(20):4485-4497.
    View in: PubMed
    Score: 0.180
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.